4 research outputs found

    Relevance Versus Irrelevance of Scientific Research Skills to the Practice of the Accounting Profession

    Get PDF
    Assessing the relevance of scientific accounting research to the practice of the profession is a topic less present in the literature, and the results of empirical research are often divided. In this context, the research aims to analyse the extent to which scientific accounting research is necessary and relevant for the practice of the profession. The views and opinions presented in this paper will represent the author's perceptions of students' and practitioners' attitudes towards indigenous accounting research, formed both from an academic perspective and from the perspective of the practicing accountant

    REVENUE FROM CONTRACTS WITH CUSTOMERS: KEY ASPECTS IN THE LIGHT OF IFRS 15

    No full text
    The present paper suggests discussing and debating the main elements that should be considered in connection with the adoption and application of the new International Financial Reporting Standard IFRS 15 “Revenue from Contracts with Customers”. Some changes, as well as opportunities are worthwhile, and it is beneficial to identify them and to analyze how to apply and capitalize on them for better quality of financial reporting. The present paper is, on the one hand, a fundamental research aiming at the acquisition of new knowledge and the development of the theory in this area of accounting and, on the other hand, an applied research as it is designed to analyse new theories and find solutions and practical applications, thus contributing to the improvement of accounting and financial reporting of revenues with a direct impact on the process of substantiation of decisions. The results of the research can be used in the development and improvement of both the relevant regulations regarding the accounting and financial reporting of revenues, and in the practical activities of legal entities, as well as in the educational process in educational institutions

    CONTABILITATEA DEPRECIERII MIJLOACELOR FIXE ÎN VIZIUNE NAŢIONALĂ ŞI INTERNAŢIONALĂ

    No full text
    Obiectivul acestui studiu este de a examina şi compara modul de recunoaştere, contabilizare şi raportare financiară a pierderii de depreciere a mijloacelor fixe din perspectiva Standardelor Naţionale de Contabilitate şi în comparaţie cu prevederile Standardelor Internaţionale de Raportare Financiară. În acest sens, pentru început au fost expuse prevederile SNC „Deprecierea activelor” cu privire la deprecierea mijloacelor fixe, avându-se în vedere cele mai importante etape ale ciclului contabil – recunoaşterea, evaluarea, înregistrarea în conturi şi prezentarea în situaţiile financiare.  Apoi, a fost urmărită prezenţa acestor etape în deprecierea mijloacelor fixe din perspectiva IAS 36 „Deprecierea activelor”, cu identificarea similitudinilor şi neconcordanţelor.ACCOUNTING OF DEPRECIATION OF FIXED ASSETS IN NATIONAL AND INTERNATIONAL TERMSThe objective of this study is to examine and compare the accounting and financial reporting of fixed assets impairment from the perspective of the National Accounting Standards and the International Financial Reporting Standards. In this respect, initially we exposed the provisions of NAS "Impairment of Assets" referring to fixed assets in view of the most important steps in the accounting cycle - recognition, measurement, recording and presentation in the financial statements. Then these steps and their presence were followed and reviewed based on the terms of IAS 36 "Impairment of Assets" regarding fixed assets, identifying the similarities and discrepancies. </p

    Study Regarding the Evolution of the Financial Balance in the Pharmaceutical Industry

    No full text
    This article aims at analysing the financial balance within the global pharmaceutical industry, starting from the assumption that „In the pharmaceutical industry there is sufficient liquidity to cover payment obligations”. The analysed companies are part of the exclusive group comprising the top 20 global companies, e.g. GlaxoSmithKline, Merck & Co., Sanofi-Aventis and Bayer. The research conducted is based on an analysis over time of the relationship between floating assets, floating assets requirement and net cash from 2006 to 2013, and highlights the main developments of the indicators before the onset of the financial and economic crisis and after its outbreak
    corecore